Navigation path
2000 Projets
Liste des projets 2000 (classés par acronyme)
(description des projets uniquement disponible en anglais)
| ADMALI | Adhesive Interactions in Malaria: New Targets for Intervention |
| AMVTNETHIC | AMVTN Workshops on the Molecular Biology and Immunology of Malaria Vaccines |
| ATTMAL | New Genetic Technologies: Applications to Generate Attenuated Malaria Vaccines |
| CASCADE | Concerted Action on SeroConversion to AIDS and Death in Europe |
| DISSARM | Development of Integrable Sensors for Screening of Antibiotic Resistance in Mycobacterium |
| ECS | European Collaborative Study on Pregnant HIV Infected Women and Their Children |
| ENVEP | European Network for Vaccine Evaluation in Primates: Combined Vector Immunisation for AIDS Vaccine Development |
| EUROMALVAC1 | A European Malaria Vaccine Development Consortium |
| EuroSIDA | The EuroSIDA network 2000-200: Clinical and Virological Outcome of European Patients Infected with HIV |
| EUROVAC I | European Vaccine Effort Against HIV/AIDS |
| EVA | Programme EVA (European Vaccine Against Aids) Centralised Facility For Aids Reagents |
| HIV COM THER | Development and Testing of a Combined Anti-Retroviral, Immune, and Gene Therapy for Treatment of HIV Patients |
| HIV RESISTANCE | New Tools to Investigate and Suppress HIV Drug Resistance |
| HIV-1 MTCT | International Network on HIV-1 Mother-to-Child Transmission: Developing Integration of Healthcare Programmes, Clinical, Social and Basic Research |
| HIV-superinfections | Behavioural, Immunological and Virologic Correlates of HIV-1 Superinfection (HIV+ vs HIV++) in Rural Tanzania |
| MALTRANS | Project Interruption of Malaria Transmission Vaccine Strategies |
| Mol.Epidemology TB | New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis |
| MUCOSAL TB VACCINE | Role of Mucosal Immunity for Protection against Tuberculosis |
| PARASAC | Organisation of an International Conference: ‘Moving targets - Parasites, Resistance and Access to Drugs’ from 4-6 December 2000 |
| PENTA | Paediatric European Network for the Treatment of AIDS |
| TARGETING NEF | The HIV-1 Pathogenicity Factor Nef as a Novel Therapeutic Target |
| TB prevention cluster | New Strategies for Treatment and Prevention of Mycobacterial Diseases |
| TB VACCINE CLUSTER | A Cluster for Tuberculosis Vaccine Development |
| VACSEL | Longitudinal Study of Correlates of Immunity to Tuberculosis in Exposed Individuals |